We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An economic evaluation of Herceptin in adjuvant setting: the Breast Cancer International Research Group 006 trial.
- Authors
Neyt, M; Albrecht, J; Cocquyt, V
- Abstract
Herceptin (trastuzumab) is a humanized monoclonal antibody that is being tested in the adjuvant setting. Cost implications of using trastuzumab, as administered in the Breast Cancer International Research Group 006 trial, are being calculated. This provides information on the treatment's value for money.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Vol 17, Issue 3, p381
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdj101